United States — Food and Drug Administration & Philip Kim
20 shared events · Importance 3 · Last updated Aug 22, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.
Philip Kim: Philip Kim is an attorney at Rosen Law Firm, providing contact information for investors interested in joining the class action lawsuit against Zoetis.
May 18, 2026 · 316 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Aldeyra Therapeutics, citing a lack of substantial evidence for the efficacy of reproxalap, which triggered the stock price drop and subsequent lawsuits.
Philip Kim: Philip Kim is an attorney at Rosen Law Firm, providing information and assistance to investors regarding the Aldeyra Therapeutics class action.
Apr 24, 2026 · 80 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Disc Medicine, Inc. regarding its bitopertin program, citing uncertainties in the new drug application.
Philip Kim: Philip Kim>>> is an attorney at Rosen Law Firm>>> and a contact person for investors interested in joining the class action.
Apr 29, 2026 · 68 articles
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Philip Kim: Attorney at Rosen Law Firm involved in the lawsuit.
Jul 27, 2026 · 293 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.
Philip Kim: Philip Kim is an attorney at Rosen Law Firm, providing contact information for investors interested in joining the class action lawsuit against ImmunityBio.
Apr 02, 2026 · 132 articles
Regulatory
United States — Food and Drug Administration: The FDA issued safety warnings about neurological complications in dogs from Zoetis' Librela, which contributed to the alleged decline in prescriptions.
Philip Kim: Philip Kim is an attorney at Rosen Law Firm providing contact information for investors to join the class action.
Jun 26, 2026 · 34 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Philip Kim interact across events, view sentiment trends, and discover connected entities.
Open Dashboard